Helex provides CRISPR based services through the proprietary platform built to enhance performance customised to clients’ needs. The platform is customised per cell-lines in order to enhance performance, and deliver high quality needs like knock-outs, knock-ins, tagging, endogenous protein tagging. Our models cater to several cell-lines including immortalised cells, iPSCs and T-cells. All of our product offerings come with certification for quality control and guaranteed results. In addition, Helex is also working on providing isogenic controls for diseases derived from healthy iPSC cells.